After the panel: Hon Hai and Sharp work together to lock the medical market

Hon Hai and Sharp shouldered the rivers and lakes, and the new battlefield was exposed. After the panel, the two sides locked in the medical market. Yesterday (24), Sharp announced that it would form a business alliance with Hon Hai's subsidiary Fabrigene (abbreviated as FB). Sharp will move through the business. The transfer method will split some of its healthcare and medical businesses into four companies, including one holding company and three operating companies. The newly established holding company will be established by FB and Sharp, and FB will be relatively large. share.

 鸿海和夏普在广州发起反攻

Sharp, a century-old store, has continued to make a face-lift. In August 2016, the new president, Dai Zhengwu, took up the post, and launched a new "ONE SHARP" policy, which means that in the future, under the highest guiding principle of Sharp, all business areas will be strengthened. Collaborate and expand through business to meet all stakeholder expectations.

Now this kind of business synergy cooperation also extends to the parent company Hon Hai. Yesterday Hon Hai announced that its subsidiary FB will invest US$25 million to acquire nearly 51.2% of Sharp's Sharp Healthcare and Medical Company KY (short for SHMKY); the remaining shareholding of 48.8% is held by Sharp. Have.

夏普合并经常损益将时隔3财年扭亏为盈 鸿海入主下渐复苏

In addition to the joint venture to establish a new SHMKY holding company, the holding company will also have three companies, including Sharp Life Science Corporation (SLS; Sharp Life Science Corporation), Sharp Healthcare (UK) (short for SHMUK; Sharp Healthcare). And Medical U.K. Limited), and Lacamas Life Sciences (LLS; Lacamas Life Sciences) to be responsible for the new business, the new company is scheduled to go online on March 1.

KF94 Mask

Kf94 Mask,Best Kf94 Mask,Kf94 Mask Any Good,Kf94 Mask Buy

Zhejiang Lanhine Medical Products Ltd. , https://www.lanheyiliao.com